Rhinorus, spray 0.1% 10 ml

Vasoconstrictor for local use in ENT practice.

Xylometazoline (imidazoline derivative) is an alpha-adrenomimetic, causes narrowing of blood vessels of nasal mucosa, eliminating its edema and hyperemia, restores nasal passageway patency, facilitates nasal breathing and improves nasal discharge in rhinitis (runny nose) of different origin.

The action of the drug starts within a few minutes after application and lasts up to 10 hours.

Indications

Active ingredient

Composition

1 ml contains:

The active ingredient:

xylometazoline hydrochloride 1 mg;

Associates:

Benzalkonium chloride,

Sodium chloride,

Disodium edetate,

Sodium dihydrophosphate dihydrate,

sodium hydrophosphate dodecahydrate,

Eucalyptus oil,

water d/i.

How to take, the dosage

Adults and children over 6 years of age should take 2-3 injections of Rinorus 0,1% solution in each nasal passage 3-4 times a day.
Do not use the drug more than 3 times a day.
Do not use the drug without a break for more than 3-5 days.

Interaction

The systemic effects may be enhanced with concomitant use of MAO inhibitors and tricyclic antidepressants.

Contraindications

Do not use with MAO inhibitors and tricyclic antidepressants or other drugs which increase BP.

The drug should be prescribed with caution in diabetes mellitus, CHD, angina III-IV functional class, prostatic hyperplasia, during lactation.

Side effects

Local reactions: with frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, paresthesias, sneezing, hypersecretion; rarely – swelling of the nasal mucosa.

Systemic reactions: vomiting, headache, palpitations, increased BP, insomnia, visual impairment, depression (with long-term use of high doses).

Overdose

Symptoms: increased side effects.

Treatment: symptomatic under medical supervision.

Similarities